Study on the application of pedicle composite tissue flap transplantation combined with fractional laser therapy in the cosmetic restoration of patients with moderate to severe burns on the head and face

[Objective:] To study the effect of pedicle composite tissue flap transplantation combined with fractional laser (FL) therapy in the cosmetic restoration of patients with moderate to severe burns of the head and face. [Methods:] A total of 82 patients with moderate to severe burns on the head and face, who attended our hospital from May 2018 to May 2023, were selected and divided into the control group and the research group, 41 cases each, using a statistical randomization method. The control group underwent pedicle composite tissue flap transplantation, while the research group received pedicle composite tissue flap transplantation combined with FL therapy. The intervention effect, flap survival rate, skin healing time, skin elasticity score, luster score, scar score, and serum tumor necrosis factor-α (TNF-α) and interleukin-8 (IL-8) levels were compared between the two groups before and after the intervention. Additionally, the number of adverse reaction cases (infection, hematoma, flap contracture, wound dehiscence) was recorded. [Results:] After the intervention, the research group was higher than the control group in terms of total treatment efficiency, flap survival rate, skin elasticity score, luster score, and scar score (P<0.05); the research group was shorter than the control group in terms of skin healing time (P<0.05); the research group was lower than the control group in terms of serum TNF-α and IL-8 levels (P<0.05); and the research group was less than the control group in terms of the number of cases of adverse reactions (P<0.05). [Conclusion:] The combination of pedicle composite tissue flap transplantation and FL therapy improves cosmetic restoration in patients with moderate to severe burns of the head and face, accelerates skin healing, reduces inflammatory irritation, and decreases adverse reactions, demonstrating significant clinical application value.